Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,735,567
-
Share change
-
+136,778
-
Total reported value
-
$787,343,415
-
Put/Call ratio
-
570%
-
Price per share
-
$27.40
-
Number of holders
-
110
-
Value change
-
+$3,934,782
-
Number of buys
-
47
-
Number of sells
-
46
Institutional Holders of GENOMIC HEALTH INC - COM (GHDX) as of Q2 2014
As of 30 Jun 2014,
GENOMIC HEALTH INC - COM (GHDX) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,735,567 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, Camber Capital Management LLC, BAILLIE GIFFORD & CO, Champlain Investment Partners, LLC, VANGUARD GROUP INC, TPG Group Holdings (SBS) Advisors, Inc., BlackRock Fund Advisors, State Street Corp, and BlackRock Institutional Trust Company, N.A..
This page lists
110
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.